WATSON 424 (Hydrochlorothiazide and triamterene 25 mg / 37.5 mg)
Pill imprint WATSON 424 has been identified as Hydrochlorothiazide and triamterene 25 mg / 37.5 mg.
Hydrochlorothiazide/triamterene is used in the treatment of edema; high blood pressure and belongs to the drug class antihypertensive combinations. Risk cannot be ruled out during pregnancy. Hydrochlorothiazide/triamterene 25 mg / 37.5 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for WATSON 424 (Hydrochlorothiazide and triamterene 25 mg / 37.5 mg)
- 25 mg / 37.5 mg
- 7.00 mm
- Prescription only
- Drug Class:
- Antihypertensive combinations
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Watson Pharmaceuticals
- National Drug Code (NDC):
- Inactive Ingredients:
- lactose anhydrous
polyethylene glycol 8000
FD&C Blue No. 2
|NDC Code||Manufacturer / Repackager|
|21695-0496||Rebel Distributors Corp (repackager)|
Note: Inactive ingredients may vary.
More about hydrochlorothiazide/triamterene
- Hydrochlorothiazide and triamterene
- Triamterene and hydrochlorothiazide (Advanced Reading)